Kenneth J. Hillan - Nov 20, 2022 Form 4 Insider Report for 23andMe Holding Co. (ME)

Role
Chief Therapeutics Officer
Signature
/s/ Kenneth Hillan, by Kathy Hibbs, attorney-in-fact
Stock symbol
ME
Transactions as of
Nov 20, 2022
Transactions value $
-$13,838
Form type
4
Date filed
11/22/2022, 03:11 PM
Previous filing
Aug 25, 2022
Next filing
Dec 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ME Class A Common Stock Tax liability -$13.8K -4.63K -2.29% $2.99 197K Nov 20, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The closing price on November 18, 2022, the fair market used for the transaction date.
F2 Includes 5,707 shares acquired under the 23andMe Holding Co. 2021 Employee Stock Purchase Plan on August 31, 2022.